Despite recent advances in novel therapies, the prognosis for patients with squamous cell
carcinoma of the head and neck (SCCHN) remains poor. Progress in understanding the …

Most head and neck cancers are derived from the mucosal epithelium in the oral cavity,
pharynx and larynx and are known collectively as head and neck squamous cell carcinoma …

Tobacco use and alcohol consumption are the main risk factors associated with head and
neck squamous cell carcinoma (SCC) development due to their cytotoxic and mutagenic …

Head and neck squamous cell carcinoma (HNSCC) is a highly aggressive solid tumor, with
a 5-year mortality rate of~ 50%. The development of immunotherapies has improved the …

Squamous cell cancer is the most common type of malignancy arising from the epithelial
cells of the head and neck region. Head and neck squamous cell carcinoma (HNSCC) is …

Overexpression of the epidermal growth factor receptor (EGFR) is a common characteristic
of head and neck squamous cell carcinomas (HNSCC). Cetuximab is a chimeric anti-EGFR …

Squamous cell carcinoma of the head and neck (SCCHN) is the sixth most common cancer
worldwide. The main risk factors for cancers of the oral cavity, larynx, oropharynx, and …

Head and neck squamous cell carcinoma (HNSCC) is often diagnosed at an advanced
stage and has a dismal prognosis. Nearly 10 years after the approval of cetuximab, anti …

Head and neck cancer consists of a diverse group of cancers that ranges from cutaneous,
lip, salivary glands, sinuses, oral cavity, pharynx and larynx. Each group dictates different …

Head and neck squamous cell carcinoma (HNSCC) is a highly heterogeneous disease that
is the result of tobacco and/or alcohol abuse or infection with high-risk Human …